Brief: Jazz Pharmaceuticals To Acquire Chimerix
05/03/2025 12:47
March 5 (Reuters) - Chimerix CMRX.O: JAZZ PHARMACEUTICALS TO ACQUIRE CHIMERIX, FURTHER DIVERSIFYING ONCOLOGY PORTFOLIO CHIMERIX INC - DEAL VALUED AT $935 MILLION, OR $8.55 PER SHARE CHIMERIX INC - JAZZ TO FUND TRANSACTION THROUGH EXISTING CASH AND INVESTMENTS Source text: ID:nPn3n9k3Ga Further company coverage: CMRX.O ((Reuters.Briefs@thomsonreuters.com;))